87
Views
42
CrossRef citations to date
0
Altmetric
Research Article

Transforming Growth Factor-Beta 1, Activin and Follistatin in Patients with Hepatocellular Carcinoma and Patients with Alcoholic Cirrhosis

Pages 233-238 | Published online: 08 Jul 2009
 

Abstract

Background: Transforming growth factor-beta 1 (TGF- β 1) exerts an inhibitory effect on DNA synthesis in hepatocytes. Activin, through different mechanisms, also exhibits an apoptotic effect on hepatocytes. Follistatin antagonizes the actions of activin. Methods: Patients with hepatocellular carcinoma (HCC, n = 20), patients with alcoholic cirrhosis ( n = 12), patients with cirrhosis due to other causes ( n = 5) and normal controls ( n = 19) were studied. TGF- β 1, activin and follistatin concentrations in blood and ascites were measured by ELISA. Results: All three groups of patients had significantly higher serum levels of total TGF- β 1, activin and follistatin compared to those of controls. In patients with HCC, the total TGF β 1 level correlated negatively with tumour size ( r =-0.644, P = 0.001). The activin level correlated with alkaline phosphatase (ALP) level ( r = 0.374, P = 0.046). The follistatin level correlated with the ALP level ( r = 0.404, P = 0.026), and the glutamyl transpeptidase level ( r = 0.457, P = 0.01). In patients with alcoholic cirrhosis, serum activin correlated with the Child-Pugh score ( r = 0.601, P = 0.01). The levels of the cytokines in ascites ( n = 16) did not correlate with the corresponding levels in serum. Conclusions: Serum levels of total TGF- β 1, activin and follistatin were elevated in patients with hepatocellular carcinoma and in patients with alcoholic cirrhosis. Apoptosis of tumour cells may be reduced by a subsequent decrease in serum TGF- β 1 levels when the tumours expand in size. Activin and follistatin were associated with tumour activity, as both correlated with ALP and/or GGT levels. Further studies are required to define the exact relationships between these cytokines, the dynamics of tumour growth and their significance in cirrhosis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.